| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001285 | Urologic Oncology: Seminars and Original Investigations | 2010 | 9 Pages |
Abstract
MI thermoablative T for small renal tumors should still be confined to carefully selected patients. PCA seems to hold the premises for the best compromise between low invasiveness and high efficacy, while RFA appears highly advantageous in terms of procedural costs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Paolo M.D., Steven M.D., Andrea M.D., Thomas M.D., Alessandro M.D., Hein M.D., Ziya M.D.,